Search results

• 2022

  Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition

  Pinton, G., Wang, Z., Balzano, C., Missaglia, S., Tavian, D., Boldorini, R., Fennell, D. A., Griffin, M. & Moro, L., 23 Nov 2022, In: Frontiers in Oncology. 12, 1 p., 1081632.

  Research output: Contribution to journal › Correction › peer-review

  Open Access

  File
• 2014

  Erratum: Celiac disease-specific TG2-targeted autoantibodies inhibit angiogenesis ex vivo and in vivo in mice by interfering with endothelial cell dynamics (PLoS ONE (2014) 9:1)

  Kalliokoski, S., Sulic, A. M., Korponay-Szabó, I. R., Szondy, Z., Frias, R., Perez, M. A., Martucciello, S., Roivainen, A., Pelliniemi, L. J., Esposito, C., Griffin, M., Sblattero, D., Mäki, M., Kaukinen, K., Lindfors, K. & Caja, S., 6 Jan 2014, In: PLoS ONE. 9, 1

  Research output: Contribution to journal › Correction › peer-review

  Open Access